13P High neutrophils-to-lymphocyte ratio (NLR) predicts poor survival of high-PD-L1-expressing metastatic non-small cell lung carcinoma patients undergoing first-line immunotherapy with pembrolizumab

13P High neutrophils-to-lymphocyte ratio (NLR) predicts poor survival of high-PD-L1-expressing metastatic non-small cell lung carcinoma patients undergoing first-line immunotherapy with pembrolizumab

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 32; p. S1379
Main Authors: Romano, F.J., Barbato, C., Arundine, D., Ambrosio, F., Ronga, R., Failla, G., Moccia, L., Corcione, N., Guggino, G., Raucci, A., Romano, L., Campione, S., De Dominicis, G., Santoriello, C., Tinto, A., Russo, C., De Michele, F., Russo, A., Starace, A., Riccardi, F.
Format: Journal Article
Language:English
Published: 01-12-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1016/j.annonc.2021.10.029